Immediately after giving effect to the Business Combination, there were 51,608,262 shares of Fathom Class A common stock outstanding. As of such time, our executive officers and directors and their affiliated entities beneficially held approximately 63.7% of our outstanding shares of Class A common stock (assuming all 84,294,971 New Fathom Units were exchanged on a one-for-one basis for shares of Class A common stock).
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Upon the completion of the Transactions, and in accordance with the terms of the Business Combination Agreement, the executive officers of Altimar II ceased serving in such capacities and Kevin Beebe, Payne Brown, Richard M. Jelinek, Roma Khanna, Michael Rubenstein, Vijay Sondhi, Michael Vorhaus and Tom Wasserman ceased serving on Altimar II’s board of directors. Carey Chen, TJ Chung, Dr. Caralynn Nowinski Collens, Adam DeWitt, David Fisher, Maria Green, Peter Leemputte, Ryan Martin, John May and Robert Nardelli were appointed as directors of Fathom, and TJ Chung was elected Chairman of the Board.
Upon the completion of the Transactions, the Company established the following three committees of the Board: audit committee, compensation committee and nominating and corporate governance committee. Dr. Caralynn Nowinski Collens, Adam DeWitt, Peter Leemputte and Robert Nardelli were appointed to serve on the Company’s audit committee, with Peter Leemputte serving as the chair and with each of Adam DeWitt and Peter Leemputte qualifying as an audit committee financial expert, as such term is defined in Item 407(d)(5) of Regulation S-K. David Fisher, Dr. Caralynn Nowinski Collens, Maria Green and Peter Leemputte were appointed to serve on the Company’s compensation committee, with David Fisher serving as the chair. Adam Dewitt, Davis Fisher, Maria Green and Robert Nardelli were appointed to serve on the Company’s nominating and corporate governance committee, with Robert Nardelli serving as the chair.
Additionally, upon completion of the Transactions, Ryan Martin was appointed as the Company’s Chief Executive Officer; Richard Stump was appointed as Chief Commercial Officer; and Mark Frost was appointed as Chief Financial Officer, Chief Accounting Officer and Corporate Secretary.
Following the completion of the Transactions, the non-employee directors of the Company will be entitled to the following compensation for their service on the Board: (i) an annual cash retainer of $50,000; (ii) an initial equity award with a grant date fair value equal to $225,000 and then an annual equity award with a target grant date fair value equal to $150,000, to be granted each year at the annual meeting of the Company’s stockholders; (iii) annual cash retainers of $20,000 for the chair of the audit committee, $15,000 for the chair of the compensation committee and $10,000 for the chair of the nominating and corporate governance committee; (iv) annual cash retainers of $10,000 for other members of the audit committee, $7,500 for other members of the compensation committee, and $5,000 for other members of the nominating and corporate governance committee; and (v) an additional annual retainer of $50,000 for serving as our non-executive chair and, if applicable, $20,000 for serving as our lead director. Each annual grant of equity-based awards described above will vest in full on the first anniversary of the grant date, or in such other circumstances as set forth in the applicable award agreement. Each initial grant of equity-based awards described above will vest in substantially equal annual installments on each
20